HIV Prevention Drug Faces Access Barriers Despite Global Potential

Experts warn that a promising injectable PrEP drug, capable of significantly reducing new HIV cases globally, faces access challenges due to dramatic worldwide declines in HIV prevention investment, including USAID cuts.

31 Jul, 16:29 — 31 Jul, 16:29

Post Share

Sources

Showing 1 of 1 sources

The GuardianMostly Factual34d ago

HIV prevention drug could reduce number of cases globally but USAID cuts prevent access, say experts

Injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide Sign up for the Breaking News US newsletter email New innovations in HIV prevention could dramatically reduce the number of new HIV cases around the globe, but US foreign aid cuts will mean that those that most need the new medication will be unable to access it, according to experts at the Aids 2026 Conference in Rio de Janeiro, Brazil. One year ago, the World Health Organization recomm...

By Hannah Harris Green in Rio de Janeiro

Read full article →

HIV Prevention Drug Faces Access Barriers Despite Global Potential

Sources

HIV prevention drug could reduce number of cases globally but USAID cuts prevent access, say experts

Related Stories

South Korea Reviews Potential Troop Deployment to Strait of Hormuz Amid Media Reports

Zurich’s Langstrasse District Nominated for UNESCO World Heritage Status

US Envoys Prepare Diplomatic Visits to Kyiv and Moscow

Missouri Legislative Candidate Charged With Attempting to Plant Cocaine on Rival